Table 3.

Radiotherapy during the years 2019, 2020 and 2021

Characteristics	Group A, year 2019, pre-COVID-19a (n = 76)	Group B, year 2020, COVID-19b (n = 71)	Group C, year 2021, COVID-19c (n = 78)	P value
Radiotherapy				0.758
Primary/definitive	49 (64.5%)	45 (63.4%)	46 (59.0%)
Adjuvant	27 (35.5%)	26 (36.6%)	32 (41.0%)
Intention of radiotherapy				0.054
Curative	66 (86.8%)	69 (97.2%)	73 (93.6%)
Palliative	10 (13.2%)	2 (2.8%)	5 (6.4%)

^aYear 2019, pre-pandemic control group

^bYear 2020, pandemic study group

^cYear 2021, a phase of partial normalization in a persistent pandemic situation